Lowest Price Guaranteed
Pages
298
Last Updated
January 2026
View Count
11984
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross-Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Virtual Biopsy
6.3. Conventional Biopsy Versus Virtual Biopsy
6.4. Steps Involved in Performing Virtual Biopsy
6.4.1. Acquisition of Data
6.4.2. Data Harmonization
6.4.3. Division of Data
6.4.4. Region of Interests (ROI) Segmentation
6.4.5. Extraction and Selection of Image Features
6.4.6. Validation of Model
6.5. Applications of Virtual Biopsy
6.5.1. Cancer Management
6.5.2. Other Therapeutic Applications
6.6. Challenges Associated with Virtual Biopsy
6.7. Future Perspectives
7. MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Virtual Biopsy Devices: Overall Market Landscape
7.2.1. Analysis by Status of Development
7.2.2. Analysis by Year of Approval
7.2.3. Analysis by Region of Approval
7.2.4. Analysis by Regulatory Accreditations
7.2.5. Analysis by Type of Step Involved
7.2.6. Analysis by Clinical Purpose
7.2.7. Analysis by Type of Imaging Technology Used
7.2.8. Analysis by Status of Development and Type of Imaging Technology Used
7.2.9. Analysis by Therapeutic Application
7.2.10. Analysis by Target Therapeutic Area
7.2.11. Analysis by Status of Development and Target Therapeutic Area
7.2.12. Analysis by Type of Cancer Targeted
7.3. Virtual Biopsy Devices: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters (Region)
7.3.4. Analysis by Status of Development and Location of Headquarters (Region)
7.3.5. Analysis by Location of Headquarters (Country)
7.3.6. Analysis by Company Size and Location of Headquarters (Region)
7.3.7. Most Active Developers: Analysis by Number of Virtual Biopsy Devices Developed
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Product Competitiveness Analysis: Virtual Biopsy Devices
8.4.1. Product Competitiveness Analysis: Virtual Biopsy Devices Developed by Players based in North America
8.4.2. Product Competitiveness Analysis: Virtual Biopsy Devices Developed by Players based in Europe and Asia-Pacific
9. COMPANY PROFILES: DEVELOPERS BASED IN NORTH AMERICA
9.1. Chapter Overview
9.2. GE HealthCare
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Virtual Biopsy Device Portfolio
9.2.4. Recent Developments and Future Outlook
9.3. Imaging Biometrics
9.4. OptoVibronex
10. COMPANY PROFILES: DEVELOPERS BASED IN EUROPE
10.1. Chapter Overview
10.2. ImageBiopsy Lab
10.2.1. Company Overview
10.2.2. Virtual Biopsy Device Portfolio
10.2.3. Recent Developments and Future Outlook
10.3. Median Technologies
10.4. Quibim
10.5. Siemens Healthineers
11. COMPANY PROFILES: VIRTUAL BIOPSY PROVIDERS BASED IN ASIA-PACIFIC
11.1. Chapter Overview
11.2. City Imaging and Clinical Labs
11.2.1. Company Overview
11.2.2. Virtual Biopsy Device Portfolio
11.2.3. Recent Developments and Future Outlook
12. PARTNERSHIPS AND COLLABORATIONS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Virtual Biopsy: Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Year and Type of Partnership
12.3.4. Analysis by Type of Partner
12.3.5. Analysis by Type of Imaging Technology
12.3.6. Analysis by Therapeutic Application
12.3.7. Most Active Players: Analysis by Number of Partnerships
12.3.8. Analysis by Geography
12.3.8.1. Local and International Agreements
12.3.8.2. Intracontinental and Intercontinental Agreements
13. FUNDING AND INVESTMENTS
13.1. Chapter Overview
13.2. Funding Models
13.3. Virtual Biopsy: Funding and Investments
13.3.1. Analysis by Year of Funding
13.3.2. Analysis by Type of Funding
13.3.3. Analysis by Year and Type of Funding
13.3.4. Analysis by Amount Invested
13.3.5. Analysis of Amount Invested by Type of Funding
13.3.6. Analysis by Geography
13.3.7. Most Active Players: Analysis by Number of Funding Instances
13.3.8. Most Active Players: Analysis by Amount Raised
13.3.9. Leading Investors: Analysis by Number of Funding Instances
13.4. Concluding Remarks
14. PATENT ANALYSIS
14.1. Chapter Overview
14.2. Scope And Methodology
14.3. Virtual Biopsy: Patent Analysis
14.3.1. Analysis by Patent Publication Year
14.3.2. Analysis by Type of Patent and Publication Year
14.3.3. Analysis by Patent Application Year
14.3.4. Analysis by Patent Jurisdiction
14.3.5. Analysis by CPC Symbols
14.3.6. Analysis by Type of Applicant
14.3.7. Leading Industry Players: Analysis by Number of Patents
14.3.8. Leading Non-Industry Players: Analysis by Number of Patents
14.4. Patent Benchmarking Analysis
14.4.1. Analysis by Patent Characteristics (CPC Codes) by Leading Industry Players
14.5. Patent Valuation
14.6. Leading Patents by Number of Citations
15. PUBLICATION ANALYSIS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Virtual Biopsy: Publication Analysis
15.3.1. Analysis by Year of Publication
15.3.2. Analysis by Type of Publication
15.3.3. Key Copyright Holders: Analysis by Number of Publications
15.3.4. Most Active Publishers: Analysis by Number of Publications
15.3.5. Key Journals: Analysis by Number of Publications
15.3.6. Key Journals: Analysis by Impact Factor
15.3.7. Publication Analysis: Most Popular Keywords
16. MARKET IMPACT ANALYSIS
16.1. Chapter Overview
16.2. Market Drivers
16.3. Market Restraints
16.4. Market Opportunities
16.5. Market Challenges
16.6. Conclusion
17. VIRTUAL BIOPSY MARKET
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Global Virtual Biopsy Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.3.1. Scenario Analysis
17.3.1.1. Conservative Scenario
17.3.1.2. Optimistic Scenario
17.4. Key Market Segmentations
18. VIRTUAL BIOPSY MARKET, BY TARGET THERAPEUTIC AREA
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Virtual Biopsy Market: Distribution by Target Therapeutic Area
18.3.1. Virtual Biopsy Market for Oncological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.2. Virtual Biopsy Market for Neurological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.3. Virtual Biopsy Market for Cardiovascular Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.4. Virtual Biopsy Market for Ophthalmological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.5. Virtual Biopsy Market for Endocrine Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.6. Virtual Biopsy Market for Gastrointestinal Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.7. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19. VIRTUAL BIOPSY MARKET, BY TYPE OF CANCER TARGETED
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Virtual Biopsy Market: Distribution by Type of Cancer Targeted
19.3.1. Virtual Biopsy Market for Solid Malignancies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2. Virtual Biopsy Market for Breast Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3. Virtual Biopsy Market for Lung Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.4. Virtual Biopsy Market for Prostate Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.5. Virtual Biopsy Market for Colorectal Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.6. Virtual Biopsy Market for Brain Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.7. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.4. Data Triangulation and Validation
20. VIRTUAL BIOPSY MARKET, BY TYPE OF IMAGING TECHNOLOGY
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Virtual Biopsy Market: Distribution by Type of Imaging Technology
20.3.1. Virtual Biopsy Market for Magnetic Resonance Imaging, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.3.2. Virtual Biopsy Market for Computed Tomography, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.3.3. Virtual Biopsy Market for X-ray, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.3.4. Virtual Biopsy Market for Ultrasound, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.3.5. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.4. Data Triangulation and Validation
21. VIRTUAL BIOPSY MARKET, BY END USERS
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Virtual Biopsy Market: Distribution by End Users
21.3.1. Virtual Biopsy Market for Hospitals and Clinics, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.3.2. Virtual Biopsy Market for Research Institutes and Diagnostic Centers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.3.3. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.4. Data Triangulation and Validation
22. VIRTUAL BIOPSY MARKET, BY GEOGRAPHICAL REGIONS
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Virtual Biopsy Market: Distribution by Geographical Regions
22.3.1. Virtual Biopsy Market for North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.1.1. Virtual Biopsy Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.1.2. Virtual Biopsy Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.1.3. Virtual Biopsy Market in Rest of North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2. Virtual Biopsy Market for Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.1. Virtual Biopsy Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.2. Virtual Biopsy Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.3. Virtual Biopsy Market in Italy, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.4. Virtual Biopsy Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.5. Virtual Biopsy Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.6. Virtual Biopsy Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.2.7. Virtual Biopsy Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3. Virtual Biopsy Market for Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3.1. Virtual Biopsy Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3.2. Virtual Biopsy Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3.3. Virtual Biopsy Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3.4. Virtual Biopsy Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3.5. Virtual Biopsy Market in Australia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.3.6. Virtual Biopsy Market in Rest of Asia Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.4. Virtual Biopsy Market for Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.4.1. Virtual Biopsy Market in Saudi Arabia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.4.2. Virtual Biopsy Market in Egypt, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.4.3. Virtual Biopsy Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.4.4. Virtual Biopsy Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.5. Virtual Biopsy Market for Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.5.1. Virtual Biopsy Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.5.2. Virtual Biopsy Market in Mexico, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.5.3. Virtual Biopsy Market in Argentina, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.3.5.4. Virtual Biopsy Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.4. Virtual Biopsy Market by Geographical Regions: Market Dynamics Assessment
22.4.1. Market Movement Analysis
22.4.2. Penetration Growth (P-G) Matrix
22.5. Data Triangulation and Validation
23. VIRTUAL BIOPSY MARKET, LEADING PLAYERS
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Virtual Biopsy Market: Distribution by Leading Players
23.4. Data Triangulation and Validation
24. CONCLUDING REMARKS
25. EXECUTIVE INSIGHTS
26. APPENDIX I: TABULATED DATA
27. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIO
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 2.3 Research Methodology: Robust Quality Control
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Market Assessment Framework
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Market Landscape
Figure 5.2 Executive Summary: Market Trends
Figure 5.3 Executive Summary: Market Sizing and Opportunity Analysis
Figure 6.1 Conventional Biopsy Versus Virtual Biopsy
Figure 6.2 Challenges Associated with Virtual Biopsy
Figure 7.1 Virtual Biopsy Devices: Distribution by Status of Development
Figure 7.2 Virtual Biopsy Devices: Distribution by Year of Approval
Figure 7.3 Virtual Biopsy Devices: Distribution by Region of Approval
Figure 7.4 Virtual Biopsy Devices: Distribution by Regulatory Accreditations
Figure 7.5 Virtual Biopsy Devices: Distribution by Type of Step Involved
Figure 7.6 Virtual Biopsy Devices: Distribution by Clinical Purpose
Figure 7.7 Virtual Biopsy Devices: Distribution by Type of Imaging Technology Used
Figure 7.8 Virtual Biopsy Devices: Distribution by Status of Development and Type of Imaging Technology Used
Figure 7.9 Virtual Biopsy Devices: Distribution by Therapeutic Application
Figure 7.10 Virtual Biopsy Devices: Distribution by Target Therapeutic Area
Figure 7.11 Virtual Biopsy Devices: Distribution by Status of Development and Target Therapeutic Area
Figure 7.12 Virtual Biopsy Devices: Distribution by Type of Cancer Targeted
Figure 7.13 Virtual Biopsy Device Developers: Distribution by Year of Establishment
Figure 7.14 Virtual Biopsy Device Developers: Distribution by Company Size
Figure 7.15 Virtual Biopsy Device Developers: Distribution by Location of Headquarters (Region)
Figure 7.16 Virtual biopsy Device Developers: Distribution by Status of Development and Location of Headquarters (Region)
Figure 7.17 Virtual biopsy Device Developers: Distribution by Location of Headquarters (Country)
Figure 7.18 Virtual Biopsy Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Figure 7.19 Most Active Developers: Distribution by Number of Virtual Biopsy Devices Developed
Figure 8.1 Product Competitiveness Analysis: Virtual Biopsy Devices Developed by Players based in North America
Figure 8.2 Product Competitiveness Analysis: Virtual Biopsy Devices Developed by Players based in Europe and Asia-Pacific
Figure 9.1 GE HealthCare: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 9.2 IQ-AI (Parent Company of Imaging Biometrics): Consolidated Financial Details (GBP Million)
Figure 10.1 Median Technologies: Consolidated Financial Details (EUR Million)
Figure 10.2 Siemens Healthineers: Business Segment-wise Revenues and Consolidated Financial Details (EUR Million)
Figure 12.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2020
Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2020
Figure 12.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 12.5 Partnerships and Collaborations: Distribution by Type of Imaging Technology
Figure 12.6 Partnerships and Collaborations: Distribution by Therapeutic Application
Figure 12.7 Most Active Players: Distribution by Number of Partnerships
Figure 12.8 Partnership and Collaborations: Local and International Agreements
Figure 12.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 13.1 Funding and Investments: Cumulative Year-wise Trend, Since 2020
Figure 13.2 Funding and Investments: Distribution by Type of Funding
Figure 13.3 Funding and Investments: Distribution by Year and Type of Funding, Since 2020
Figure 13.4 Funding and Investments: Distribution by Amount Invested, Since 2020 (USD Million)
Figure 13.5 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 13.6 Funding and Investments: Distribution by Geography (Region)
Figure 13.7 Most Active Players: Distribution by Number of Funding Instances
Figure 13.8 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 13.9 Leading Investors: Distribution by Number of Funding Instances
Figure 13.10 Funding and Investment Summary, Since 2020 (USD Million)
Figure 14.1 Patent Analysis: Distribution by Type of Patent
Figure 14.2 Patent Analysis: Cumulative Distribution by Patent Publication Year, Since 2019
Figure 14.3 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, Since 2019
Figure 14.4 Patent Analysis: Distribution by Patent Application Year, Since Pre-2018
Figure 14.5 Patent Analysis: Patent Jurisdiction
Figure 14.6 Patent Analysis: Distribution by CPC Symbols
Figure 14.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, Since 2019
Figure 14.8 Leading Industry Players: Distribution by Number of Patents
Figure 14.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 14.10 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) by Leading Industry Players
Figure 14.11 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)
Figure 14.12 Patent Analysis: Distribution by Patent Age
Figure 14.13 Virtual Biopsy: Patent Valuation
Figure 15.1 Publication Analysis: Cumulative Year-wise Trend, Since Pre-2019
Figure 15.2 Publication Analysis: Distribution by Type of Publication
Figure 15.3 Key Copyright Holders: Distribution by Number of Publications
Figure 15.4 Most Active Publishers: Distribution by Number of Publications
Figure 15.5 Key Journals: Distribution by Number of Publications
Figure 15.6 Key Journals: Distribution by Impact Factor
Figure 15.7 Publication Analysis: Most Popular Keywords
Figure 17.1 Global Virtual Biopsy Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.2 Global Virtual Biopsy Market, Forecasted Estimates (Till 2035): Conservative Scenario (USD Billion)
Figure 17.3 Global Virtual Biopsy Market, Forecasted Estimates (Till 2035): Optimistic Scenario (USD Billion)
Figure 18.1 Virtual Biopsy Market: Distribution by Target Therapeutic Area
Figure 18.2 Virtual Biopsy Market for Oncological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.3 Virtual Biopsy Market for Neurological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.4 Virtual Biopsy Market for Cardiovascular Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.5 Virtual Biopsy Market for Ophthalmological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.6 Virtual Biopsy Market for Endocrine Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.7 Virtual Biopsy Market for Gastrointestinal Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.8 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.1 Virtual Biopsy Market: Distribution by Type of Cancer Targeted
Figure 19.2 Virtual Biopsy Market for Solid Malignancies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.3 Virtual Biopsy Market for Breast Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.4 Virtual Biopsy Market for Lung Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.5 Virtual Biopsy Market for Prostate Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.6 Virtual Biopsy Market for Colorectal Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.7 Virtual Biopsy Market for Brain Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.8 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.1 Virtual Biopsy Market: Distribution by Imaging Technology
Figure 20.2 Virtual Biopsy Market for Magnetic Resonance Imaging, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.3 Virtual Biopsy Market for Computed Tomography, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.4 Virtual Biopsy Market for X-ray, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.5 Virtual Biopsy Market for Ultrasound, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.6 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.1 Virtual Biopsy Market: Distribution by End Users
Figure 21.2 Virtual Biopsy Market for Hospitals and Clinics, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.3 Virtual Biopsy Market for Research Institutes and Diagnostic Centers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.4 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.1 Virtual Biopsy Market: Distribution by Geographical Regions
Figure 22.2 Virtual Biopsy Market in North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.3 Virtual Biopsy Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.4 Virtual Biopsy Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.5 Virtual Biopsy Market in Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.6 Virtual Biopsy Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.7 Virtual Biopsy Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.8 Virtual Biopsy Market in Italy, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.9 Virtual Biopsy Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.10 Virtual Biopsy Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.11 Virtual Biopsy Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.12 Virtual Biopsy Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.13 Virtual Biopsy Market in Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.14 Virtual Biopsy Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.15 Virtual Biopsy Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.16 Virtual Biopsy Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.17 Virtual Biopsy Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.18 Virtual Biopsy Market in Australia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.19 Virtual Biopsy Market in Rest of Asia Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.20 Virtual Biopsy Market in Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.21 Virtual Biopsy Market in Saudi Arabia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.22 Virtual Biopsy Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.23 Virtual Biopsy Market in Egypt, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.24 Virtual Biopsy Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.25 Virtual Biopsy Market in Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.26 Virtual Biopsy Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.27 Virtual Biopsy Market in Mexico, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.28 Virtual Biopsy Market in Argentina, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.29 Virtual Biopsy Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.30 Market Movement Analysis: Geographical Regions
Figure 22.31 Penetration Growth Matrix: Geographical Regions
Figure 23.1 Virtual Biopsy Market: Distribution by Leading Players (USD Billion)
Figure 24.1 Conclusion: Market Landscape
Figure 24.2 Conclusion: Partnerships and Collaborations
Figure 24.3 Conclusion: Funding and Investments
Figure 24.4 Conclusion: Patent Analysis
Figure 24.5 Conclusion: Publication Analysis
Figure 24.6 Conclusion: Market Sizing and Opportunity Analysis (I / II)
Figure 24.7 Conclusion: Market Sizing and Opportunity Analysis (II / II)
Table 7.1 Virtual Biopsy Devices: Information on Developer, Status of Development, Year of Approval, Region of Approval and Regulatory Accreditations
Table 7.2 Virtual Biopsy Devices: Information on Type of Step Involved and Clinical Purpose
Table 7.3 Virtual Biopsy Devices: Information on Type of Imaging Technology Used and Therapeutic Application
Table 7.4 Virtual Biopsy Devices: Information on Target Therapeutic Area
Table 7.5 Virtual Biopsy Devices: Information on Type of Cancer Targeted
Table 7.6 Virtual Biopsy Devices: Information on List of Developers
Table 9.1 Virtual Biopsy Device Developers based in North America: List of Companies Profiled
Table 9.2 GE HealthCare: Company Overview
Table 9.3 GE HealthCare: Virtual Biopsy Device Portfolio
Table 9.4 GE HealthCare: Recent Developments and Future Outlook
Table 9.5 Imaging Biometrics (Acquired by IQ-AI): Company Overview
Table 9.6 Imaging Biometrics (Acquired by IQ-AI): Virtual Biopsy Device Portfolio
Table 9.7 OptoVibronex: Company Overview
Table 9.8 OptoVibronex: Virtual Biopsy Device Portfolio
Table 10.1 Virtual Biopsy Device Developers based in Europe: List of Companies Profiled
Table 10.2 ImageBiopsy Lab: Company Overview
Table 10.3 ImageBiopsy Lab: Virtual Biopsy Device Portfolio
Table 10.4 ImageBiopsy Lab: Recent Developments and Future Outlook
Table 10.5 Median Technologies: Company Overview
Table 10.6 Median Technologies: Virtual Biopsy Device Portfolio
Table 10.7 Median Technologies: Recent Developments and Future Outlook
Table 10.8 Quibim: Company Overview
Table 10.9 Quibim: Virtual Biopsy Device Portfolio
Table 10.10 Quibim: Recent Developments and Future Outlook
Table 10.11 Siemens Healthineers: Company Overview
Table 10.12 Siemens Healthineers: Virtual Biopsy Device Portfolio
Table 11.1 Virtual Biopsy Device Developers based in Asia Pacific: List of Companies Profiled
Table 11.2 City Imaging and Clinical Labs: Company Overview
Table 11.3 City Imaging and Clinical Labs: Virtual Biopsy Device Portfolio
Table 11.4 City Imaging and Clinical Labs: Recent Developments and Future Outlook
Table 12.1 Virtual Biopsy Device Developers: List of Partnerships and Collaborations, Since 2020
Table 12.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement (Country and Region)
Table 13.1 Virtual Biopsy Devices: List of Funding and Investments, Since 2020
Table 14.1 Patent Analysis: Top CPC Sections
Table 14.2 Patent Analysis: Top CPC Symbols
Table 14.3 Patent Analysis: Top CPC Codes
Table 14.4 Patent Analysis: Summary of Benchmarking Analysis
Table 14.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 14.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 14.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 25.1 GENECAST: Company Snapshot
Table 25.2 Quibim: Company Snapshot
Table 26.1 Virtual Biopsy Devices: Distribution by Status of Development
Table 26.2 Virtual Biopsy Devices: Distribution by Year of Approval
Table 26.3 Virtual Biopsy Devices: Distribution by Region of Approval
Table 26.4 Virtual Biopsy Devices: Distribution by Regulatory Accreditations
Table 26.5 Virtual Biopsy Devices: Distribution by Type of Step Involved
Table 26.6 Virtual Biopsy Devices: Distribution by Clinical Purpose
Table 26.7 Virtual Biopsy Devices: Distribution by Type of Imaging Technology Used
Table 26.8 Virtual Biopsy Devices: Distribution by Status of Development and Type of Imaging Technology Used
Table 26.9 Virtual Biopsy Devices: Distribution by Therapeutic Application
Table 26.10 Virtual Biopsy Devices: Distribution by Target Therapeutic Area
Table 26.11 Virtual Biopsy Devices: Distribution by Status of Development and Target Therapeutic Area
Table 26.12 Virtual Biopsy Devices: Distribution by Type of Cancer Targeted
Table 26.13 Virtual Biopsy Device Developers: Distribution by Year of Establishment
Table 26.14 Virtual Biopsy Device Developers: Distribution by Company Size
Table 26.15 Virtual Biopsy Device Developers: Distribution by Location of Headquarters (Region)
Table 26.16 Virtual biopsy Device Developers: Distribution by Status of Development and Location of Headquarters (Region)
Table 26.17 Virtual biopsy Device Developers: Distribution by Location of Headquarters (Country)
Table 26.18 Virtual Biopsy Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Table 26.19 Most Active Developers: Distribution by Number of Virtual Biopsy Devices Developed
Table 26.20 GE HealthCare: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Table 26.21 IQ-AI (Parent Company of Imaging Biometrics): Consolidated Financial Details (GBP Million)
Table 26.22 Median Technologies: Consolidated Financial Details (EUR Million)
Table 26.23 Siemens Healthineers: Business Segment-wise Revenues and Consolidated Financial Details (EUR Million)
Table 26.24 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2020
Table 26.25 Partnerships and Collaborations: Distribution by Type of Partnership
Table 26.26 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2020
Table 26.27 Partnerships and Collaborations: Distribution by Type of Partner
Table 26.28 Partnerships and Collaborations: Distribution by Type of Imaging Technology
Table 26.29 Partnerships and Collaborations: Distribution by Therapeutic Application
Table 26.30 Most Active Players: Distribution by Number of Partnerships
Table 26.31 Partnership and Collaborations: Local and International Agreements
Table 26.32 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 26.33 Funding and Investments: Cumulative Year-wise Trend, Since 2020
Table 26.34 Funding and Investments: Distribution by Type of Funding
Table 26.35 Funding and Investments: Distribution by Year and Type of Funding, Since 2020
Table 26.36 Funding and Investments: Distribution by Amount Invested, Since 2020 (USD Million)
Table 26.37 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Table 26.38 Funding and Investments: Distribution by Geography (Region)
Table 26.39 Most Active Players: Distribution by Number of Funding Instances
Table 26.40 Most Active Players: Distribution by Amount Raised (USD Million)
Table 26.41 Leading Investors: Distribution by Number of Funding Instances
Table 26.42 Funding and Investment Summary, Since 2020 (USD Million)
Table 26.43 Patent Analysis: Distribution by Type of Patent
Table 26.44 Patent Analysis: Cumulative Distribution by Patent Publication Year, Since 2019
Table 26.45 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, Since 2019
Table 26.46 Patent Analysis: Distribution by Patent Application Year, Since Pre-2018
Table 26.47 Patent Analysis: Patent Jurisdiction
Table 26.48 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, Since 2019
Table 26.49 Leading Industry Players: Distribution by Number of Patents
Table 26.50 Leading Non-Industry Players: Distribution by Number of Patents
Table 26.51 Patent Analysis: Distribution by Patent Age
Table 26.52 Virtual Biopsy: Patent Valuation
Table 26.53 Publication Analysis: Cumulative Year-wise Trend, Since Pre-2019
Table 26.54 Publication Analysis: Distribution by Type of Publication
Table 26.55 Key Copyright Holders: Distribution by Number of Publications
Table 26.56 Most Active Publishers: Distribution by Number of Publications
Table 26.57 Key Journals: Distribution by Number of Publications
Table 26.58 Key Journals: Distribution by Impact Factor
Table 26.59 Publication Analysis: Most Popular Keywords
Table 26.60 Global Virtual Biopsy Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.61 Global Virtual Biopsy Market, Forecasted Estimates (Till 2035): Conservative Scenario (USD Billion)
Table 26.62 Global Virtual Biopsy Market, Forecasted Estimates (Till 2035): Optimistic Scenario (USD Billion)
Table 26.63 Virtual Biopsy Market: Distribution by Target Therapeutic Area
Table 26.64 Virtual Biopsy Market for Oncological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.65 Virtual Biopsy Market for Neurological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.66 Virtual Biopsy Market for Cardiovascular Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.67 Virtual Biopsy Market for Ophthalmological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.68 Virtual Biopsy Market for Endocrine Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.69 Virtual Biopsy Market for Gastrointestinal Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.70 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.71 Virtual Biopsy Market: Distribution by Type of Cancer Targeted
Table 26.72 Virtual Biopsy Market for Solid Malignancies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.73 Virtual Biopsy Market for Breast Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.74 Virtual Biopsy Market for Lung Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.75 Virtual Biopsy Market for Prostate Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.76 Virtual Biopsy Market for Colorectal Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.77 Virtual Biopsy Market for Brain Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.78 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.79 Virtual Biopsy Market: Distribution by Imaging Technology
Table 26.80 Virtual Biopsy Market for Magnetic Resonance Imaging, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.81 Virtual Biopsy Market for Computed Tomography, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.82 Virtual Biopsy Market for X-ray, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.83 Virtual Biopsy Market for Ultrasound, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.84 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.85 Virtual Biopsy Market: Distribution by End Users
Table 26.86 Virtual Biopsy Market for Hospitals and Clinics, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.87 Virtual Biopsy Market for Research Institutes and Diagnostic Centers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.88 Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.89 Virtual Biopsy Market: Distribution by Geographical Regions
Table 26.90 Virtual Biopsy Market in North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.91 Virtual Biopsy Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.92 Virtual Biopsy Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.93 Virtual Biopsy Market in Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.94 Virtual Biopsy Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.95 Virtual Biopsy Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.96 Virtual Biopsy Market in Italy, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.97 Virtual Biopsy Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.98 Virtual Biopsy Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.99 Virtual Biopsy Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.100 Virtual Biopsy Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.101 Virtual Biopsy Market in Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.102 Virtual Biopsy Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.103 Virtual Biopsy Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.104 Virtual Biopsy Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.105 Virtual Biopsy Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.106 Virtual Biopsy Market in Australia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.107 Virtual Biopsy Market in Rest of Asia Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.108 Virtual Biopsy Market in Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.109 Virtual Biopsy Market in Saudi Arabia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.110 Virtual Biopsy Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.111 Virtual Biopsy Market in Egypt, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.112 Virtual Biopsy Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 035) (USD Billion)
Table 26.113 Virtual Biopsy Market in Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.114 Virtual Biopsy Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.115 Virtual Biopsy Market in Mexico, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.116 Virtual Biopsy Market in Argentina, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.117 Virtual Biopsy Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.118 Virtual Biopsy Market: Distribution by Leading Players (USD Billion)
Please reach out to our team for more details.